<DOC>
	<DOCNO>NCT00571922</DOCNO>
	<brief_summary>This clinical trial compare 10 week treatment acamprosate ( 2 gr/day ) versus placebo , combine weekly abstinence orient individual counseling , methamphetamine dependent patient , 72 subject enrol , interim analysis schedule 36 enrol . Primary outcome methamphetamine absitience 10 week treatment period , last 2 week treatment . Abstinence define weekly basis urine positive methamphetamine ( amphetamine ) self-report use 7 day period . Secondary measure include treatment retention , drug craving , mood , safety .</brief_summary>
	<brief_title>A Clinical Trial Acamprosate Treatment Methamphetamine Addiction</brief_title>
	<detailed_description />
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>Methamphetamine dependence Treatment seek Urine sample ( + ) methamphetamine Pregnancy Dependence drug ( except nicotine ) DSMIV axis I disorder unrelated drug abuse Serious medical condition clinician opinion . AIDs Untreated syphilis Allergy acamprosate Methadone , ORP , maintenance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>methamphetamine , crystal , treatment</keyword>
</DOC>